Skip to main content
Neurotherapeutics logoLink to Neurotherapeutics
. 2021 Apr 27;18(2):1426. doi: 10.1007/s13311-021-01035-4

Correction to: Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis

Adham Fani Maleki 1, Giulia Cisbani 1, Nataly Laflamme 1, Paul Prefontaine 1, Marie-Michele Plante 1, Joanie Baillargeon 1, Manu Rangachari 1, Jean Gosselin 2, Serge Rivest 1,
PMCID: PMC8423889  PMID: 33907979

https://doi.org/10.1007/s13311-020-00998-0

   This article was corrected to add the captions to the supplementary figures.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES